Maryland CC Project
Maryland CC Project
Maryland CC Project
Shanholtz – Acute Respiratory Distress Syndrome
1 hour 5 minutes Posted Aug 9, 2019 at 12:00 pm.
0:00
1:05:34
Download MP3
Show notes


@import url('https://fonts.googleapis.com/css?family=Merriweather&display=swap');
p, li, h1, h2, h3, h4 {font-family: 'Merriweather', serif;font-size:18px; color:black;}




Carl Shanholtz, MD, Professor of Medicine in the Division of Pulmonary and Critical Care and Director of the Medical ICU at the University of Maryland presents the multi-departmental critical care curriculum lecture on ARDS.









Lecture Summary by Dr. Jason Nam



Introduction



* ARDS is a common disorder of acute injury to
lungs. It can occur in children. Lack of standard definition prior to 1994. * Why use P/F ratio in the definition? It is a
surrogate measure of shunt. Shunt fraction needs to be done with Swann-Ganz. * Consensus Conference definitions- between
American and European




Characteristic

AECC Definition 1994

Berlin Definition 2012

Timing

Acute, without any specification

Maximum within a week after a trigger insult

Imaging

Chest X-ray with bilateral infiltrates

Chest X-ray or CT scan with bilateral infiltrates, not fully
explained by effusion, lung collapse or nodules

Non-cardiogenic source of edema

Confirmation of non-elevated left atrial pressure

Respiratory failure not completely explained by excessive
volume loading or cardiac failure

Classification

Based on PaO2/FiO2
Based on PaO2/FiO2 calculated with PEEP >5 cmH2O
 
Acute lung injury:<300 Mild: 201-300
 
ARDS:<200 Moderate: 101-200
 
 – Severe: <100
Predisposing condition

Not specified

If none identified, then need to rule out cardiogenic edema
with additional data




Pathophysiology



* Active exudative phase. Leads to the pulmonary
edema (non-cardiogenic). Loss of compliance and hypoxemia refractory to supplemental
oxygen. Loss of capillary surface area and increase in dead space. We get “baby
lungs.”* When we try to ventilate, we get VILI.



Lung protection strategies



* ARMA Trial – mortality was lower, and ventilator-free days higher in the group treated with lower tidal volumes * Improvement in oxygenation doesn’t seem to predict outcome of ARDS. Oxygenation was a bad surrogate for outcome. * Is there a safe plateau pressure? At any quartile. The lower TV patients had an improved mortality. * Is higher PEEP protective? It was thought that moderate-to-severe ARDS patients would benefit from higher alveolar recruitment. Gattinoti, et al, found that moderate-to-severe ARDS patients had more atelectatic and thereby more recruitable lung. * What about driving pressure? driving pressure is directly proportional to mortality regardless of driving pressure and PEEP. No one yet knows how to titrate driving pressures as there is current evidence and interest in closed-lung strategies.* Does lung prevention ventilation strategies prevent ARDS? PReVENT trial. Multicenter RCT in Netherlands. A low tidal volume strategy did not result in a greater number of ventilator-free days than an intermediate tidal volume strategy



Fluid Management and ARDS



* Fluid and Catheter
Treatment Trial
– Fluid conservative vs.